Jessica Hope Roark

Array ( [id] => 12106304 [patent_doc_number] => 09862774 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-01-09 [patent_title] => 'Pharmaceutical composition for treatment and/or prevention of cancer' [patent_app_type] => utility [patent_app_number] => 14/910878 [patent_app_country] => US [patent_app_date] => 2014-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26135 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14910878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9864194 [patent_doc_number] => 20150044212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-12 [patent_title] => 'Antibodies Directed to GPNMB and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 14/454179 [patent_app_country] => US [patent_app_date] => 2014-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 49633 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14454179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11184799 [patent_doc_number] => 09416191 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-16 [patent_title] => 'Pharmaceutical composition for treatment and/or prevention of cancer' [patent_app_type] => utility [patent_app_number] => 14/452746 [patent_app_country] => US [patent_app_date] => 2014-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 23044 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14452746 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9864685 [patent_doc_number] => 20150044704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-12 [patent_title] => 'MONOCLONAL ANTIBODIES AND DIAGNOSTIC USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/452372 [patent_app_country] => US [patent_app_date] => 2014-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15148 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14452372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10988911 [patent_doc_number] => 20160185856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-30 [patent_title] => 'Anti-Claudin 1 Antibodies and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 14/909362 [patent_app_country] => US [patent_app_date] => 2014-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 19213 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14909362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10812220 [patent_doc_number] => 20160158380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-09 [patent_title] => 'Anti-Claudin 1 Antibodies for Use in the Treatment of Colorectal Cancer' [patent_app_type] => utility [patent_app_number] => 14/909238 [patent_app_country] => US [patent_app_date] => 2014-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 13912 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14909238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11038886 [patent_doc_number] => 20160235842 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-18 [patent_title] => 'MEDICAL USES OF CD38 AGONISTS' [patent_app_type] => utility [patent_app_number] => 14/904814 [patent_app_country] => US [patent_app_date] => 2014-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 27997 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14904814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10306532 [patent_doc_number] => 20150191531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-09 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF CYTOMEGALOVIRUS INFECTIONS' [patent_app_type] => utility [patent_app_number] => 14/323537 [patent_app_country] => US [patent_app_date] => 2014-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 35579 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14323537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10911764 [patent_doc_number] => 20140314780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-23 [patent_title] => 'Compositions Using Antibodies Directed to GPNMB and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 14/321102 [patent_app_country] => US [patent_app_date] => 2014-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 38102 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14321102 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11304825 [patent_doc_number] => 09512211 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-06 [patent_title] => 'Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume' [patent_app_type] => utility [patent_app_number] => 14/311840 [patent_app_country] => US [patent_app_date] => 2014-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 16 [patent_no_of_words] => 27902 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14311840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12009722 [patent_doc_number] => 09803027 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-31 [patent_title] => 'Method for decreasing immunogenicity' [patent_app_type] => utility [patent_app_number] => 14/308936 [patent_app_country] => US [patent_app_date] => 2014-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 8415 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14308936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10960414 [patent_doc_number] => 20140363442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-11 [patent_title] => 'THERAPEUTIC CD47 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 14/302348 [patent_app_country] => US [patent_app_date] => 2014-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 23082 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14302348 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10905290 [patent_doc_number] => 20140308302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-16 [patent_title] => 'ANTI-5T4 ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/290345 [patent_app_country] => US [patent_app_date] => 2014-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 30310 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14290345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10919204 [patent_doc_number] => 20140322223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-30 [patent_title] => 'TOX3 AS A BIOMARKER FOR BREAST CANCER' [patent_app_type] => utility [patent_app_number] => 14/284094 [patent_app_country] => US [patent_app_date] => 2014-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11208 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14284094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10737330 [patent_doc_number] => 20160083480 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-24 [patent_title] => 'Bispecific HER2 and HER3 Antigen Binding Constructs' [patent_app_type] => utility [patent_app_number] => 14/888580 [patent_app_country] => US [patent_app_date] => 2014-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 44606 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 31 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14888580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11018308 [patent_doc_number] => 20160215261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-28 [patent_title] => 'Nucleic Acid Of Coded GPC3 Chimeric Antigen Receptor Protein And T Lymphocyte Expressing GPC3 Chimeric Antigen Receptor Protein' [patent_app_type] => utility [patent_app_number] => 14/889778 [patent_app_country] => US [patent_app_date] => 2014-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 12099 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14889778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10729635 [patent_doc_number] => 20160075783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-17 [patent_title] => 'ANTIBODIES DIRECTED AGAINST PROGRAMMED DEATH-1 (PD-1)' [patent_app_type] => utility [patent_app_number] => 14/888557 [patent_app_country] => US [patent_app_date] => 2014-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18551 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14888557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10762297 [patent_doc_number] => 20160108450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-21 [patent_title] => 'SIALYLATED GLYCOPROTEINS' [patent_app_type] => utility [patent_app_number] => 14/787403 [patent_app_country] => US [patent_app_date] => 2014-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18598 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14787403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11100910 [patent_doc_number] => 20160297881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-13 [patent_title] => 'BISPECIFIC ANTIBODIES AGAINST CD3EPSILON and ROR1' [patent_app_type] => utility [patent_app_number] => 14/783775 [patent_app_country] => US [patent_app_date] => 2014-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 28764 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14783775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9641899 [patent_doc_number] => 20140220010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-07 [patent_title] => 'VARIANTS OF HUMANIZED IMMUNOMODULATORY MONOCLONAL ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 14/217599 [patent_app_country] => US [patent_app_date] => 2014-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15953 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14217599 [rel_patent_id] =>[rel_patent_doc_number] =>)